15-99712504-CCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAG
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001319206.4(MEF2A):c.1280_1285delAGCAGC(p.Gln427_Gln428del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.314 in 1,520,352 control chromosomes in the GnomAD database, including 55,836 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.26 ( 6336 hom., cov: 0)
Exomes 𝑓: 0.32 ( 49500 hom. )
Consequence
MEF2A
NM_001319206.4 disruptive_inframe_deletion
NM_001319206.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.55
Genes affected
MEF2A (HGNC:6993): (myocyte enhancer factor 2A) The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 15-99712504-CCAGCAG-C is Benign according to our data. Variant chr15-99712504-CCAGCAG-C is described in ClinVar as [Benign]. Clinvar id is 403080.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.392 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEF2A | NM_001319206.4 | c.1280_1285delAGCAGC | p.Gln427_Gln428del | disruptive_inframe_deletion | 12/12 | ENST00000557942.6 | NP_001306135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEF2A | ENST00000557942.6 | c.1280_1285delAGCAGC | p.Gln427_Gln428del | disruptive_inframe_deletion | 12/12 | 5 | NM_001319206.4 | ENSP00000453095.1 |
Frequencies
GnomAD3 genomes AF: 0.262 AC: 39321AN: 150108Hom.: 6332 Cov.: 0
GnomAD3 genomes
AF:
AC:
39321
AN:
150108
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.324 AC: 39230AN: 121148Hom.: 3821 AF XY: 0.334 AC XY: 21443AN XY: 64250
GnomAD3 exomes
AF:
AC:
39230
AN:
121148
Hom.:
AF XY:
AC XY:
21443
AN XY:
64250
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.320 AC: 438038AN: 1370124Hom.: 49500 AF XY: 0.322 AC XY: 217168AN XY: 675480
GnomAD4 exome
AF:
AC:
438038
AN:
1370124
Hom.:
AF XY:
AC XY:
217168
AN XY:
675480
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.262 AC: 39321AN: 150228Hom.: 6336 Cov.: 0 AF XY: 0.264 AC XY: 19376AN XY: 73292
GnomAD4 genome
AF:
AC:
39321
AN:
150228
Hom.:
Cov.:
0
AF XY:
AC XY:
19376
AN XY:
73292
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
MEF2A-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 31, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at